Myriad revisited still upholds DNA patenting

被引：0

|

作者：

不详

机构：

来源：

NATURE REVIEWS DRUG DISCOVERY | 2012年 / 11卷 / 10期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：742 / 742

页数：1

相关论文

共 50 条

[1] Patenting Human Genes: The Myriad Controversy
Chuang, Chester S.
Lau, Denys T.
CLINICAL THERAPEUTICS, 2010, 32 (12) : 2054 - 2056
[2] Court upholds broad plant patenting rights
不详
NATURE BIOTECHNOLOGY, 2002, 20 (01) : 9 - 9
[3] Australian court upholds Myriad's gene patent
Charlotte Harrison
Nature Reviews Drug Discovery, 2014, 13 : 805 - 805
[4] Patenting DNA Sequences After the Myriad Decision: New Frontiers or Just More of the Same?
Lawson, Charles
BIOTECHNOLOGY LAW REPORT, 2014, 33 (01) : 3 - 16
[5] Patenting genes in a post-myriad world
Fraser, Janis
Rosen, Michael
Industrial Biotechnology, 2013, 9 (04) : 163 - 164
[6] Patenting software, revisited
Stern, RH
IEEE MICRO, 1996, 16 (02) : 5 - &
[7] PATENT WATCH Australian court upholds Myriad's gene patent
Harrison, Charlotte
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (11) : 805 - 805
[8] Patenting genomics innovations: Post-myriad challenges & possibilities
Chatterjee T.
Chatterjee, Tuhin (tuhin.nujs@gmail.com), 1600, ThinkBiotech LLC (23): : 55 - 59
[9] Patenting of pharmaceuticals - Still a challenge?
Schneider, Dieter R.
IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW, 2008, 39 (05) : 511 - 525
[10] Small firms and patenting revisited
Athreye, Suma S.
Fassio, Claudio
Roper, Stephen
SMALL BUSINESS ECONOMICS, 2021, 57 (01) : 513 - 530

← 1 2 3 4 5 →